Moreover, the overexpression of RNA-binding motif protein 3 (RBM3) facilitated proliferation and drug resistance via the β-catenin pathway in colon cancer cells [12, 13]; however, it indicated a favorable prognosis in breast cancer [14]. The gene discussed is RBM3; the disease is malignant colon neoplasm.